A detailed history of Lumina Fund Management LLC transactions in Cure Vac N.V. stock. As of the latest transaction made, Lumina Fund Management LLC holds 1,500 shares of CVAC stock, worth $3,990. This represents 0.08% of its overall portfolio holdings.

Number of Shares
1,500
Holding current value
$3,990
% of portfolio
0.08%

Shares

0 transactions
Quarter Operation Price Per share shares change shares Held SEC Form

Others Institutions Holding CVAC

About CureVac N.V.


  • Ticker CVAC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 187,467,008
  • Market Cap $499M
  • Description
  • CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...
More about CVAC
Track This Portfolio

Track Lumina Fund Management LLC Portfolio

Follow Lumina Fund Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lumina Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lumina Fund Management LLC with notifications on news.